Tools

LEADER 07998cam 2200577 i 4500

001 ssj0001928320;

003 WaSeSS;

005 20210713080458.0;

006 m d ;

007 cr n ;

008 170802s2017 enka sb 001 0 eng d;

010 a| 2017275509;

016 7 a| 1017140472| DNLM;

020 a| 9780081009635q| (print);

020 a| 0081009631q| (print);

020 z| 9780081009680 (online);

035 a| (WaSeSS)ssj0001928320;

042 a| pcc;

049 a| EREEa| NEHH;

050 00 a| TA418.9.N35b| N2464 2017;

082 00 a| 610.28/42| 23;

245 00 a| Nanobiomaterials science, development and evaluationh| [electronic resource] /c| edited by Mehdi Razavi, Avnesh Thakor.;

260 a| Duxford, United Kingdom ;a| Cambridge, MA :b| Elsevier/Woodhead Publishing,c| [2017];

300 a| xi, 327 pages :b| illustrations;

490 1 a| Woodhead Publishing series in biomaterials;

504 a| Includes bibliographical references and index.;

505 00 a| Machine generated contents note:g| 1.t| Introduction /r| Mehdi Razavi --t| References --g| 2.t| Particles/Fibers/Bulk /r| Mehdi Razavi --g| 2.1.t| Introduction --g| 2.2.t| Organic biomaterials --g| 2.3.t| Inorganic biomaterials --g| 2.4.t| Organic -- inorganic biomaterials --g| 2.5.t| Concluding remarks --g| 2.6.t| Future research --g| 2.7.t| Conflict of interest --t| References --g| 3.t| Porous scaffolds /r| Gulgun Yener --g| 3.1.t| Tissue engineering --g| 3.2.t| Scaffolds --g| 3.3.t| The critical structural and chemical requirements of scaffolds --g| 3.4.t| Scaffolding biomaterials --g| 3.5.t| Naturally derived biopolymers --g| 3.6.t| Synthetic biopolymers --g| 3.7.t| Calcium phosphate bioceramics --g| 3.8.t| Bioactive glasses --g| 3.9.t| Glass -- ceramics --g| 3.10.t| Scaffold fabrication techniques --g| 3.11.t| Conclusion --t| References --g| 4.t| Naturally based and biologically derived nanobiomaterials /r| Yu S. Zhang --g| 4.1.t| Introduction --g| 4.2.t| Polysaccharide-based nanomaterials --g| 4.3.t| Collagen-based nanobiomaterials --g| 4.4.t| Carbon-based nanobiomaterials --g| 4.5.t| Conclusions and future perspectives --g| 4.6.t| Conflict of interest --g| 4.7.t| Acknowledgment --t| References --g| 5.t| Nanogels for biomedical applications: Drug delivery, imaging, tissue engineering, and biosensors /r| Wanting Niu --t| Abbreviations --g| 5.1.t| Introduction --g| 5.2.t| Materials and methods for selected nanogel systems --g| 5.3.t| Nanogels as carriers for bioactive molecules delivery --g| 5.4.t| Tissue engineering applications -- potential applications of nanogels in selected fields --g| 5.5.t| Nanogels in oncology --g| 5.6.t| Biosensor --g| 5.7.t| Conclusion and future prospective --t| References --t| Further Reading --g| 6.t| Lipid-based nanobiomaterials /r| Mehdi Razavi --g| 6.1.t| Introduction --g| 6.2.t| Applications --g| 6.3.t| Classification of SLNs --g| 6.4.t| Classification of NLC --g| 6.5.t| Preparation methods --g| 6.6.t| Conclusion --t| References --g| 7.t| Peptide-based nanobiomaterials /r| Kubra Gozutok --g| 7.1.t| Introduction --g| 7.2.t| Peptides --g| 7.3.t| Peptide nanomaterials --g| 7.4.t| Advantages of peptide-based nanomaterials --g| 7.5.t| Applications of peptide-based nanomaterials --g| 7.6.t| Conclusion and future trends --t| Acknowledgment --t| References --g| 8.t| Nanoparticles hybridization to engineer biomaterials for drug delivery /r| Jayakumar Rajadas --g| 8.1.t| Introduction --g| 8.2.t| Nanoparticles hybridization techniques --g| 8.3.t| Polymer -- biomacromolecule hybrid --g| 8.4.t| Bioinspired hybrid --g| 8.5.t| NPs hybridization to overcome biological barriers --g| 8.6.t| Conclusion --t| References --g| 9.t| Nanotherapeutics in the management of infections and cancer /r| Alexandru Mihai Grumezescu --g| 9.1.t| Introduction --g| 9.2.t| Nanotherapeutics with antimicrobial properties --g| 9.3.t| Nanotherapeutics with antitumor properties --g| 9.4.t| Conclusions --t| References --g| 10.t| Nanostructured coatings for biomaterials /r| Abdolreza Simchi --g| 10.1.t| Introduction --g| 10.2.t| Biocompatible nanostructured coatings --g| 10.3.t| Antibacterial coatings --g| 10.4.t| Conclusion and future directions --t| References --g| 11.t| Evaluation techniques /r| Ayse Candayan --g| 11.1.t| Introduction --g| 11.2.t| Structural characterizations using microscopy techniques --g| 11.3.t| Biomechanical properties --g| 11.4.t| Cell/biomaterials interactions --g| 11.5.t| Stem cells --g| 11.6.t| Biocorrosion --g| 11.7.t| Biodegradation --g| 11.8.t| In vitro assessments --g| 11.9.t| In vivo assessments --g| 11.10.t| Conclusion --g| 11.11.t| Future aspects --t| References --g| 12.t| Nanotoxicity /r| Milica Radisic --g| 12.1.t| Introduction --g| 12.2.t| In vitro cell-based toxicity assays --g| 12.3.t| Analysis of toxicity in vivo --g| 12.4.t| Nanomaterial toxicity --g| 12.5.t| Future trends --g| 12.6.t| Conclusions --t| References --g| 13.t| Immune response to nanobiomaterials /r| Frank Witte --g| 13.1.t| Introduction --g| 13.2.t| The effect of particle size --g| 13.3.t| The immune system responds to nanobiomaterials --g| 13.4.t| The effect of surface properties in biological systems --g| 13.5.t| How primary and secondary states of nanobiomaterials interfere with biological environments --g| 13.6.t| Health risks of nanobiomaterials --t| References --t| Further Reading --g| 14.t| Safety, regulatory issues, long-term biotoxicity, and the processing environment /r| Amirsalar Khandan --g| 14.1.t| Introduction --g| 14.2.t| Safety factors --g| 14.3.t| Nanoparticle biomaterials safety --g| 14.4.t| Targets of drug deliver targets and hazard assessment --g| 14.5.t| Reaction of nanoparticles for clinical applications --g| 14.6.t| Characterization for different exposure routes --g| 14.7.t| Legal aspects of biomaterials --g| 14.8.t| Long-term testing in vivo --g| 14.9.t| Global regulatory strategy and intended use --g| 14.10.t| Biological and environment reaction --g| 14.11.t| Conclusions and future trends --t| References --g| 15.t| Practical aspects /r| Aysen E. Ozel --g| 15.1.t| Introduction --g| 15.2.t| Part I: Nanomaterials and their types --g| 15.3.t| Part II: The uses of nanomaterials --g| 15.4.t| Part III: Common nanoparticles and their harmful effects --g| 15.5.t| Conclusions and future directions --t| References --g| 16.t| Summary and future of nanomaterials in medicine/biomaterials /r| M. Miraftab --g| 16.1.t| What are nanomaterials and why are they important? --g| 16.2.t| What is their application in healthcare and medicine? --g| 16.3.t| Modified implants --g| 16.4.t| What are their potentials and future prospects? --g| 16.5.t| Conclusion --t| References.;

506 a| Available only to authorized users.;

538 a| Mode of access: World Wide Web;

650 0 a| Biomedical materials.=| ^A520;

650 0 a| Nanostructured materials.=| ^A584488;

650 12 a| Nanostructuresx| classification.=| ^A946737;

650 12 a| Nanostructuresx| therapeutic use.=| ^A1065973;

650 22 a| Biocompatible Materialsx| therapeutic use.=| ^A926891;

650 7 a| Biomedical materials.2| fast0| (OCoLC)fst00832586;

650 7 a| Nanostructured materials.2| fast0| (OCoLC)fst01032630;

655 0 a| Electronic books.=| ^A491897;

700 1 a| Razavi, Mehdic| (Specialist in regenerative medicine)?| UNAUTHORIZED;

700 1 a| Thakor, Avnesh.?| UNAUTHORIZED;

830 0 a| Woodhead Publishing series in biomaterials.x| 2049-9485=| ^A1250575;

856 40 z| Full text available from eBook - Materials Science 2017 [EBCMS17]u| https://go.openathens.net/redirector/ecu.edu?url=https%3A%2F%2Fwww.sciencedirect.com%2Fscience%2Fbook%2F9780081009635;

947 a| (OCoLC)ocn964303421;

949 a| CLICK ON WEB ADDRESSw| ASISh| JOYNER188;

949 a| CLICK ON WEB ADDRESSw| ASISh| HSL77;

949 a| CLICK ON WEB ADDRESSw| ASISh| JMUSIC60;

596 a| 1 3 4;

998 a| 5246584;

999 a| CLICK ON WEB ADDRESSw| ASISc| 1i| 5246584-1001l| JNETm| JOYNERr| Ys| Yt| JNESSBKu| 2/17/2020x| EBOOKz| JERESOURCE;

999 a| CLICK ON WEB ADDRESSw| ASISc| 1i| 5246584-2001l| HSLELECm| HSLr| Ys| Yt| HEBKu| 2/17/2020x| EBOOKz| HERESOURCE;

999 a| CLICK ON WEB ADDRESSw| ASISc| 1i| 5246584-3001l| MNETm| JMUSICr| Ys| Yt| MNESSBKu| 2/17/2020x| EBOOKz| JERESOURCE;

Nanobiomaterials science, development and evaluation / edited by Mehdi Razavi, Avnesh Thakor.

Other author	Razavi, Mehdi (Specialist in regenerative medicine)
Other author	Thakor, Avnesh.
Format	Electronic
Publication Info	Duxford, United Kingdom ; Cambridge, MA : Elsevier/Woodhead Publishing, [2017]
Description	xi, 327 pages : illustrations
Supplemental Content	Full text available from eBook - Materials Science 2017 [EBCMS17]
Subjects	Biomedical materials. Nanostructured materials. Nanostructures--classification. Nanostructures--therapeutic use. Biocompatible Materials--therapeutic use.

Series	Woodhead Publishing series in biomaterials Woodhead Publishing series in biomaterials. 2049-9485 ^A1250575
Contents	Machine generated contents note: 1. Introduction / Mehdi Razavi -- References -- 2. Particles/Fibers/Bulk / Mehdi Razavi -- 2.1. Introduction -- 2.2. Organic biomaterials -- 2.3. Inorganic biomaterials -- 2.4. Organic -- inorganic biomaterials -- 2.5. Concluding remarks -- 2.6. Future research -- 2.7. Conflict of interest -- References -- 3. Porous scaffolds / Gulgun Yener -- 3.1. Tissue engineering -- 3.2. Scaffolds -- 3.3. The critical structural and chemical requirements of scaffolds -- 3.4. Scaffolding biomaterials -- 3.5. Naturally derived biopolymers -- 3.6. Synthetic biopolymers -- 3.7. Calcium phosphate bioceramics -- 3.8. Bioactive glasses -- 3.9. Glass -- ceramics -- 3.10. Scaffold fabrication techniques -- 3.11. Conclusion -- References -- 4. Naturally based and biologically derived nanobiomaterials / Yu S. Zhang -- 4.1. Introduction -- 4.2. Polysaccharide-based nanomaterials -- 4.3. Collagen-based nanobiomaterials -- 4.4. Carbon-based nanobiomaterials -- 4.5. Conclusions and future perspectives -- 4.6. Conflict of interest -- 4.7. Acknowledgment -- References -- 5. Nanogels for biomedical applications: Drug delivery, imaging, tissue engineering, and biosensors / Wanting Niu -- Abbreviations -- 5.1. Introduction -- 5.2. Materials and methods for selected nanogel systems -- 5.3. Nanogels as carriers for bioactive molecules delivery -- 5.4. Tissue engineering applications -- potential applications of nanogels in selected fields -- 5.5. Nanogels in oncology -- 5.6. Biosensor -- 5.7. Conclusion and future prospective -- References -- Further Reading -- 6. Lipid-based nanobiomaterials / Mehdi Razavi -- 6.1. Introduction -- 6.2. Applications -- 6.3. Classification of SLNs -- 6.4. Classification of NLC -- 6.5. Preparation methods -- 6.6. Conclusion -- References -- 7. Peptide-based nanobiomaterials / Kubra Gozutok -- 7.1. Introduction -- 7.2. Peptides -- 7.3. Peptide nanomaterials -- 7.4. Advantages of peptide-based nanomaterials -- 7.5. Applications of peptide-based nanomaterials -- 7.6. Conclusion and future trends -- Acknowledgment -- References -- 8. Nanoparticles hybridization to engineer biomaterials for drug delivery / Jayakumar Rajadas -- 8.1. Introduction -- 8.2. Nanoparticles hybridization techniques -- 8.3. Polymer -- biomacromolecule hybrid -- 8.4. Bioinspired hybrid -- 8.5. NPs hybridization to overcome biological barriers -- 8.6. Conclusion -- References -- 9. Nanotherapeutics in the management of infections and cancer / Alexandru Mihai Grumezescu -- 9.1. Introduction -- 9.2. Nanotherapeutics with antimicrobial properties -- 9.3. Nanotherapeutics with antitumor properties -- 9.4. Conclusions -- References -- 10. Nanostructured coatings for biomaterials / Abdolreza Simchi -- 10.1. Introduction -- 10.2. Biocompatible nanostructured coatings -- 10.3. Antibacterial coatings -- 10.4. Conclusion and future directions -- References -- 11. Evaluation techniques / Ayse Candayan -- 11.1. Introduction -- 11.2. Structural characterizations using microscopy techniques -- 11.3. Biomechanical properties -- 11.4. Cell/biomaterials interactions -- 11.5. Stem cells -- 11.6. Biocorrosion -- 11.7. Biodegradation -- 11.8. In vitro assessments -- 11.9. In vivo assessments -- 11.10. Conclusion -- 11.11. Future aspects -- References -- 12. Nanotoxicity / Milica Radisic -- 12.1. Introduction -- 12.2. In vitro cell-based toxicity assays -- 12.3. Analysis of toxicity in vivo -- 12.4. Nanomaterial toxicity -- 12.5. Future trends -- 12.6. Conclusions -- References -- 13. Immune response to nanobiomaterials / Frank Witte -- 13.1. Introduction -- 13.2. The effect of particle size -- 13.3. The immune system responds to nanobiomaterials -- 13.4. The effect of surface properties in biological systems -- 13.5. How primary and secondary states of nanobiomaterials interfere with biological environments -- 13.6. Health risks of nanobiomaterials -- References -- Further Reading -- 14. Safety, regulatory issues, long-term biotoxicity, and the processing environment / Amirsalar Khandan -- 14.1. Introduction -- 14.2. Safety factors -- 14.3. Nanoparticle biomaterials safety -- 14.4. Targets of drug deliver targets and hazard assessment -- 14.5. Reaction of nanoparticles for clinical applications -- 14.6. Characterization for different exposure routes -- 14.7. Legal aspects of biomaterials -- 14.8. Long-term testing in vivo -- 14.9. Global regulatory strategy and intended use -- 14.10. Biological and environment reaction -- 14.11. Conclusions and future trends -- References -- 15. Practical aspects / Aysen E. Ozel -- 15.1. Introduction -- 15.2. Part I: Nanomaterials and their types -- 15.3. Part II: The uses of nanomaterials -- 15.4. Part III: Common nanoparticles and their harmful effects -- 15.5. Conclusions and future directions -- References -- 16. Summary and future of nanomaterials in medicine/biomaterials / M. Miraftab -- 16.1. What are nanomaterials and why are they important? -- 16.2. What is their application in healthcare and medicine? -- 16.3. Modified implants -- 16.4. What are their potentials and future prospects? -- 16.5. Conclusion -- References.
Bibliography note	Includes bibliographical references and index.
Access restriction	Available only to authorized users.
Technical details	Mode of access: World Wide Web
Genre/form	Electronic books.
LCCN	2017275509
ISBN	9780081009635 (print)
ISBN	0081009631 (print)

Availability

Library	Location	Call Number	Status	Item Actions
	Electronic Resources	Access Content Online	✔ Available

Nanobiomaterials science, development and evaluation / edited by Mehdi Razavi, Avnesh Thakor.

Click here for more information about this title

Availability